BillionToOne

🔬 What’s next for prenatal testing? Join us for an exclusive presentation on Wednesday, 5/28 With UNITY Fetal Risk™ Screen, we’re redefining what’s possible in prenatal care: one maternal blood draw, as early as 9 weeks, delivers precise, pregnancy‑specific risk for up to 14 actionable recessive and X‑linked conditions—no partner sample required. Hear directly from the clinical, product, and commercial leaders behind the development of the NEW expanded panel for UNITY Fetal Risk™ Screen, and learn how it can transform your practice. 📅 Wednesday, May 28th ⏰ Your choice of a Lunch or Evening session ➡️ Designed for OBs, MFMs, GCs & care teams. Save your spot: https://lnkd.in/eTnbf8vx #PrenatalCare #GeneticScreening #UNITYFetalRisk #MedicalWebinar #WomensHealth

The BillionToOne #BioPharma team is headed to #ASCO25! Join us at Booth #11043 to see how our ultra sensitive, QCT™-powered liquid biopsy assays are solving key R&D challenges Northstar Select® – Detects >50% more confirmed alterations at low VAF; reaches superior CNA calls and resolution & calling sensitivity for acquired resistance mechanisms — even in the low shedding tumor types. Northstar Response® – Methylation-based, 0.01% LoD tissue-free, and built for longitudinal, pan-cancer monitoring Bring us your hard to solve biomarker research problems—let’s explore how we can help accelerate your development. 📅 Schedule time with our team: https://lnkd.in/g3AJpZsH Ezequiel Renzulli Matthew Varga, PhD #LiquidBiopsy #PrecisionOncology #ctDNA #BiomarkerDiscovery #ClinicalTrials #NorthstarSelect #NorthstarResponse #QCT #ASCO25 #BioPharmaInnovation

UNITY is lighting up Times Square ⭐ We’re proud to see UNITY on the Nasdaq Tower in Times Square — a bold reminder of our mission: setting the new standard in prenatal testing. This moment is more than a milestone — it's a celebration of innovation and the impact of accessible and patient-first healthcare. Together, we're empowering families with earlier, more accurate answers during one of life’s most important journeys. To our team, partners, and providers who believe in a better future — thank you for helping make this vision a reality. The future of prenatal care is here. #UNITY #PrenatalTesting #Nasdaq #Biotech #PrecisionMedicine #HealthcareInnovation #BillionToOne #TimesSquare #ProudMoment #TeamWork

What an incredible experience at the ACOG Annual Meeting! A huge thank you to everyone who stopped by the UNITY Hat Lab, created custom hats, attended our product theater for the exciting launch of 14-gene, and joined us for our networking dinner. Your presence made the event truly unforgettable. At UNITY, we’re proud to continue breaking barriers with 14-gene. Where others stop, we keep going—bringing advanced solutions to reproductive health and prenatal care. We’re thrilled to share this innovation with the amazing OBGYN community and dedicated healthcare professionals like you. We hope you walked away with new insights, connections, and perhaps a few new ideas to enhance your work in prenatal care. Stay tuned for what’s next—we’re just getting started! 🚀 Visit our website today to learn more https://lnkd.in/eHqd99mu #14Gene #ACOG #ACOG2025 #prenatalcare #OBGYN

🧬 We're back for day two at ACOG! Join us today at 12 PM at Booth #121 for an exclusive Product Theater presentation with our VP of Medical Affairs, Prenatal, Jennifer Hoskovec. We’re thrilled to unveil the expanded UNITY Fetal Risk™ Screen, now covering 14 recessive conditions! This innovation sets a new standard in comprehensive prenatal care, and you can be among the first to learn what’s next in fetal risk screening. Plus, don’t miss the Unity Hat Lab, happening today from 12 PM to 2 PM at Booth #121. Come by, connect with us, and experience the latest advancements in prenatal screening. We can’t wait to see you there! #UNITYScreen #PrenatalCare #OBGYN #GeneticScreening #ACOG #ACOG25 #MedicalInnovation

We’re thrilled to welcome Dr. Haywood L. Brown as our new Chief Medical Officer, Prenatal at BillionToOne. Dr. Brown is one of the most respected voices in maternal-fetal medicine, with over 30 years of leadership in clinical care, research, and health equity. He is a past President of ACOG, SMFM, and AGOS, and has been a relentless advocate for maternal health, particularly in underserved communities. His appointment marks a major milestone as we recently surpassed 1 million UNITY® prenatal screens—a testament to our commitment to making high-precision, non-invasive prenatal testing more accessible than ever before. Welcome, Dr. Brown! We’re honored to have you on this journey. 🎉 Read the full announcement ➡️ https://lnkd.in/eqe4uquq #BillionToOne #UNITYTest #MaternalHealth #PrenatalCare #HealthEquity #WomensHealth #Leadership 

🎉 We’re live at #ACOG2025! Join us today at 2 PM CST at Booth #121 for an exclusive Product Theater presentation with our VP of Medical Affairs, Prenatal, Jennifer Hoskovec. We’ll be unveiling the expanded UNITY Fetal Risk™ Screen — now covering 14 recessive conditions — setting a new standard in comprehensive prenatal care. Be among the first to see what’s next in fetal risk screening. We can’t wait to share it with you. https://lnkd.in/ePRRRv-U #UNITYScreen #PrenatalCare #OBGYN #GeneticScreening #ACOG #MedicalInnovation

🚀 BillionToOne Expands UNITY Fetal Risk™ Screen with 14-Gene Offering We're proud to announce the expansion of our UNITY Fetal Risk Screen, now covering up to 14 recessive and X-linked conditions—all from a single maternal blood draw, as early as 9 weeks into pregnancy. Powered by our proprietary QCT™ technology, UNITY Complete remains the only cell-free prenatal screening test that can provide direct insights to fetal risk for up to 14 recessive conditions, aneuploidies, and more, without a paternal sample. This launch marks a major step forward in making accurate, accessible prenatal care a reality for all. Read more: https://lnkd.in/eSHh6q4m #PrenatalTesting #BillionToOne #UNITYScreen #InnovationInHealthcare

We’re looking forward to connecting at #ASCO25 in Chicago! Join us at Booth #11043 to see how Northstar is bringing single-molecule precision to liquid biopsy—giving clinicians powerful tools to detect and monitor advanced cancer with clarity and confidence. Whether you’re interested in therapy selection, response monitoring, or research opportunities—we’d love to connect. 📍 Booth #11043 📅 Schedule a time to meet with our team: https://lnkd.in/g3AJpZsH #NorthstarOncology #BillionToOne #ASCO25 #PrecisionOncology #LiquidBiopsy #ctDNA #CancerCare

To every mom—expecting, new, or seasoned—thank you for letting us be part of your journey. You inspire us every day, and we're honored to support you with insights about your baby’s health. Happy Mother’s Day 🌸 #MothersDay #PrenatalCare #UNITYScreen